0001493152-19-010763.txt : 20190718 0001493152-19-010763.hdr.sgml : 20190718 20190718090011 ACCESSION NUMBER: 0001493152-19-010763 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190718 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190718 DATE AS OF CHANGE: 20190718 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXIEN BIOPHARMA, INC. CENTRAL INDEX KEY: 0001625288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262049376 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-55320 FILM NUMBER: 19960546 BUSINESS ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 BUSINESS PHONE: 3034957583 MAIL ADDRESS: STREET 1: 4340 E KENTUCKY AVE STREET 2: SUITE 206 CITY: GLENDALE STATE: CO ZIP: 80246 FORMER COMPANY: FORMER CONFORMED NAME: Intiva BioPharma Inc. DATE OF NAME CHANGE: 20171129 FORMER COMPANY: FORMER CONFORMED NAME: Kinder Holding Corp. DATE OF NAME CHANGE: 20141114 8-K 1 form8-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (date of earliest event reported): July 18, 2019

 

Nexien BioPharma, Inc.

(Exact name of registrant as specified in its charter)

 

Commission File No.: 0-55320

 

Delaware   26-2049376
(State or other jurisdiction
of incorporation)		   (I.R.S. Employer
Identification No.)

 

4340 E Kentucky Ave, Suite 206, Glendale, CO   80246
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (303) 495-7583

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 
 

 

Item 7.01 Regulation FD Disclosure.

 

On July 18, 2019, Nexien BioPharma, Inc. issued a press release about the granting of a patent pertaining to the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity by the Israeli Patent Office. This Form 8-K and the information included as exhibits shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended (“Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing. The furnishing of the information in this report is not intended to, and does not, constitute a determination or admission by the Company that the information in this report is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Registrant or any of its affiliates.

 

Item 9.01 Financial Statements and Exhibits.

 

Regulation
S-K Number		   Document
99.1   Press release dated July 18, 2019

 

2
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEXIEN BIOPHARMA, INC.

 

/s/: Alex Wasyl  
Alex Wasyl, Chief Executive Officer  
July 18, 2019  

 

3
 

 

EXHIBIT INDEX

 

Regulation
S-K Number		   Document
99.1   Press release dated July 18, 2019

 

4
 

 

 

 EX-99.1 2 ex99-1.htm

 

 

Nexien BioPharma announces that it has been granted a patent by the Israeli Patent
Office covering the use of cannabinoids and terpenes for treatment of
organophosphate and carbamate toxicity - two common nerve agents

 

Denver, CO, July 18, 2019 – Nexien BioPharma, Inc. (“Nexien” or the “Company”) (OTCQB: NXEN), a next generation biopharmaceutical company focused on research, development and commercialization of novel FDA-compliant cannabinoid pharmaceuticals and related drug delivery systems, today announced that it was granted Patent No. 238946 for “Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity” by the Israeli Patent Office.

 

The endocannabinoid system and other physiological systems can potentially mitigate the effects of organophosphate and carbamate toxicity when treated with medicaments affecting these systems in a time and dose-dependent format.

 

Nexien’s unique process for treating symptoms incorporates a composition comprising tetrahydrocannabinol and cannabidiol formulated for administration by an oral, nasal, buccal, sublingual, parenteral, or any combination thereof.

 

Alex Wasyl, Nexien’s Chief Executive Officer, stated, “We are pleased to announce a milestone in Nexien’s patent development - the granting of our first patent in Israel. While we continue to build our entire patent estate, this achievement puts Nexien in a better position to advance our clinical investigation of cannabinoid drug formulations and delivery systems for the acute treatment during exposure of poisoning from organophosphorus nerve agents.”

 

About Organophosphate and Carbamate Toxicity

 

Organophosphate and carbamate compounds are typically used as insecticides, pesticides, petroleum additives and petrochemicals. Organophosphate and carbamate have also been developed for use as chemical warfare nerve agents, such as Sarin. While some of these compounds are banned in developed countries, they are mostly inexpensive and accessible, especially in poorer countries. It is estimated that at least 750,000 cases of organophosphate poisoning occur every year with an estimated 300,000 fatalities a year world-wide.

 

About Nexien BioPharma, Inc.

 

Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals in accordance with U.S. Food and Drug Administration (“FDA”) pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma website: www.nexienbiopharma.com.

 

Forward Looking Statements

 

Nexien Disclosure Notice: This press release may contain “forward-looking statements, which are deemed to be any statements made by or on behalf of Nexien BioPharma that are not statements of historical facts. These statements reflect current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this release, including the factors set forth in “Risk Factors” in our most recent Form 10-K filed with the Securities and Exchange Commission (SEC) and subsequent filings with the SEC. Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. Nexien BioPharma undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

 

Contacts

 

Nexien BioPharma, Inc.

info@nexienbiopharma.com

 

The Equity Group

Lena Cati

(212) 836-9611

Lcati@equityny.com

 

Devin Sullivan

(212) 836-9608

dsullivan@equityny.com

 

 
 

 

 GRAPHIC 3 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end